Janssen to Monitor Remicade IBD Treatment for Free in Patients

Janssen to Monitor Remicade IBD Treatment for Free in Patients
Janssen Biotech is partnering with Miraca Life Sciences and its InformTx therapeutic drug monitoring service to develop the Janssen 2Inform program for patients with inflammatory bowel disease (IBD) being treated with Remicade (infliximab). The InformTx monitoring service allows clinicians to personalize IBD management for patients by assessing drug and anti-drug antibody blood levels for the biologic drugs

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Lynne Longworth says:

    I am struggling to pay for my health insurance, because of crohn’s disease my remicade treatments are over $25,000 every 8 weeks. I am grateful to being doing so well after my surgery that saved my life back in December 2011 . Now my monthly health insurance is $1,233.69 a month with a deductable of over $4,000 . It is an ongoing issue that will never end. I am feeling well although the health insurance will make me sick. Is there any research that would help me pay for the remicade treatments? 6 times a year

Leave a Comment

Your email address will not be published. Required fields are marked *